Gene Report
Approved Symbol | IL6 |
---|---|
Approved Name | interleukin 6 (interferon, beta 2) |
Previous Symbol | IFNB2 |
Symbol Alias | IL-6, BSF2, HGF, HSF |
Location | 7p21-p15 |
Position | chr7:22766766-22771621 (+) |
External Links |
Entrez Gene: 3569 Ensembl: ENSG00000136244 UCSC: uc003svj.4 HGNC ID: 6018 |
No. of Studies (Positive/Negative) | 1(0/1) |
Type | Literature-origin; Protein mapped |
Network loading ...
Note:
1. The different color of the nodes denotes the level of the nodes.
Genetic/Epigenetic Locus | Protein and Other Molecule | Cell and Molecular Pathway | Neural System | Cognition and Behavior | Symptoms and Signs | Environment | MDD |
2. User can drag the nodes to rearrange the layout of the network. Click the node will enter the report page of the node. Right-click will show also the menus to link to the report page of the node and remove the node and related edges. Hover the node will show the level of the node and hover the edge will show the evidence/description of the edge.
3. The network is generated using Cytoscape Web
Name in Literature | Reference | Research Type | Statistical Result | Relation Description |
---|---|---|---|---|
IL6 | Hong CJ, 2005 | Patients and nomal controls | No significant differences were demonstrated for the genoty...... No significant differences were demonstrated for the genotype or allele frequency of the IL-6 polymorphism when comparing the MDD and control groups More... |
Approved Name | UniportKB | No. of Studies (Positive/Negative) | Source | |
---|---|---|---|---|
Interleukin-6 | P05231 | 17(15/2) | Literature-origin |
Literature-origin GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0006954 | inflammatory response | biological process | IDA[10443688] |
Gene mapped GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0060445 | branching involved in salivary gland morphogenesis | biological process | IEA | |
GO:0031175 | neuron projection development | biological process | IMP[3264880] | |
GO:0006469 | negative regulation of protein kinase activity | biological process | IEA | |
GO:0016049 | cell growth | biological process | IEA | |
GO:0007568 | aging | biological process | IEA | |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | biological process | IDA[7508917] | |
GO:0042102 | positive regulation of T cell proliferation | biological process | IDA[3130269] | |
GO:0008083 | growth factor activity | molecular function | IDA[2261637] | |
GO:0002446 | neutrophil mediated immunity | biological process | IC[16034137] | |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | biological process | IEA | |
GO:0002690 | positive regulation of leukocyte chemotaxis | biological process | IC[16034137] | |
GO:0033160 | positive regulation of protein import into nucleus, translocation | biological process | IEA | |
GO:0046849 | bone remodeling | biological process | IEA | |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | biological process | IEA | |
GO:0008360 | regulation of cell shape | biological process | IEA | |
GO:0009408 | response to heat | biological process | IEA | |
GO:0050829 | defense response to Gram-negative bacterium | biological process | IEP[16034137] | |
GO:0045079 | negative regulation of chemokine biosynthetic process | biological process | ISS | |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | biological process | IDA[17324931] | |
GO:1901215 | negative regulation of neuron death | biological process | IEA | |
GO:0032496 | response to lipopolysaccharide | biological process | IEA | |
GO:0032868 | response to insulin stimulus | biological process | IEA | |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | biological process | IDA[7508917] | |
GO:0050710 | negative regulation of cytokine secretion | biological process | IEA | |
GO:0045765 | regulation of angiogenesis | biological process | IC[8557680] | |
GO:0032722 | positive regulation of chemokine production | biological process | IDA[10510402]; IMP[16034137] | |
GO:0005576 | extracellular region | cellular component | TAS | |
GO:0032494 | response to peptidoglycan | biological process | IEP[16034137] | |
GO:0030168 | platelet activation | biological process | TAS[7831669] | |
GO:0042832 | defense response to protozoan | biological process | IEA | |
GO:0042110 | T cell activation | biological process | IEA | |
GO:0005138 | interleukin-6 receptor binding | molecular function | IPI[12829785]; IPI[12829785]; NAS[1883960] | |
GO:0050871 | positive regulation of B cell activation | biological process | IDA[3491322] | |
GO:0045599 | negative regulation of fat cell differentiation | biological process | NAS[16464856] | |
GO:0051384 | response to glucocorticoid stimulus | biological process | IDA[10443688] | |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | biological process | IDA[7749983] | |
GO:0005615 | extracellular space | cellular component | IDA[3023045] | |
GO:0051024 | positive regulation of immunoglobulin secretion | biological process | IDA[3491322] | |
GO:0001781 | neutrophil apoptotic process | biological process | IDA[7595060] | |
GO:0045666 | positive regulation of neuron differentiation | biological process | IEA | |
GO:0043200 | response to amino acid stimulus | biological process | IEA | |
GO:0051607 | defense response to virus | biological process | IDA[3023045] | |
GO:0046888 | negative regulation of hormone secretion | biological process | IEA | |
GO:0045721 | negative regulation of gluconeogenesis | biological process | IEA | |
GO:0006959 | humoral immune response | biological process | IC[3491322] | |
GO:0050679 | positive regulation of epithelial cell proliferation | biological process | IEA | |
GO:0009409 | response to cold | biological process | IEA | |
GO:0010888 | negative regulation of lipid storage | biological process | NAS[16464856] | |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | IEA | |
GO:0002548 | monocyte chemotaxis | biological process | IC[10510402] | |
GO:0019221 | cytokine-mediated signaling pathway | biological process | IDA[2261637] | |
GO:0051897 | positive regulation of protein kinase B signaling cascade | biological process | IEA | |
GO:0031018 | endocrine pancreas development | biological process | ISS[18719127] | |
GO:0042493 | response to drug | biological process | IEA | |
GO:0009897 | external side of plasma membrane | cellular component | IEA | |
GO:0046677 | response to antibiotic | biological process | IEA | |
GO:0070301 | cellular response to hydrogen peroxide | biological process | IDA[19168699] | |
GO:0045740 | positive regulation of DNA replication | biological process | IEA | |
GO:0046716 | muscle cell homeostasis | biological process | IEA | |
GO:0045454 | cell redox homeostasis | biological process | IEA | |
GO:0048635 | negative regulation of muscle organ development | biological process | IEA | |
GO:0042981 | regulation of apoptotic process | biological process | IDA[9949178] | |
GO:0008284 | positive regulation of cell proliferation | biological process | IDA[2261637]; IMP[18719127] | |
GO:0032966 | negative regulation of collagen biosynthetic process | biological process | IDA[12419823] | |
GO:0043066 | negative regulation of apoptotic process | biological process | IDA[7595060]; IMP[18719127] | |
GO:0045727 | positive regulation of translation | biological process | IDA[16732314] | |
GO:0005896 | interleukin-6 receptor complex | cellular component | IDA[2261637] | |
GO:0009612 | response to mechanical stimulus | biological process | IEA | |
GO:0043410 | positive regulation of MAPK cascade | biological process | IDA[12419823] | |
GO:0070102 | interleukin-6-mediated signaling pathway | biological process | IDA[12552091] | |
GO:0045669 | positive regulation of osteoblast differentiation | biological process | TAS[12372336] | |
GO:0050830 | defense response to Gram-positive bacterium | biological process | IEP[16034137] | |
GO:0032755 | positive regulation of interleukin-6 production | biological process | IDA[10510402] | |
GO:0005125 | cytokine activity | molecular function | IDA[3023045]; NAS[10443688] | |
GO:0051602 | response to electrical stimulus | biological process | IEA | |
GO:0008285 | negative regulation of cell proliferation | biological process | IEA | |
GO:0002675 | positive regulation of acute inflammatory response | biological process | IDA[2444978] | |
GO:0048661 | positive regulation of smooth muscle cell proliferation | biological process | IDA[10510402] | |
GO:0070091 | glucagon secretion | biological process | ISS[18719127] | |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | biological process | IEA | |
GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein | biological process | IDA[12643274] | |
GO:0046427 | positive regulation of JAK-STAT cascade | biological process | IDA[17324931] | |
GO:2000366 | positive regulation of STAT protein import into nucleus | biological process | IC[17324931] | |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | biological process | IEA | |
GO:0045893 | positive regulation of transcription, DNA-dependent | biological process | IDA[7749983] | |
GO:0051971 | positive regulation of transmission of nerve impulse | biological process | IEA | |
GO:0002384 | hepatic immune response | biological process | IDA[2444978]; TAS[12832423] | |
GO:0031000 | response to caffeine | biological process | IEA | |
GO:0010574 | regulation of vascular endothelial growth factor production | biological process | IDA[8557680] | |
GO:0051592 | response to calcium ion | biological process | IEA | |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | biological process | IEA | |
GO:0006953 | acute-phase response | biological process | TAS[12832423] | |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | biological process | IDA[12419823] | |
GO:0031667 | response to nutrient levels | biological process | IEA |
Literature-origin KEGG pathway | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
hsa05332 | graft versus_host_disease | Graft-versus-host disease | Graft-versus-host disease (GVHD) pathophysiology can be summ...... Graft-versus-host disease (GVHD) pathophysiology can be summerized in a three-step process. During step 1, the conditioning regimen (irradiation and/or chemotherapy) leads to damage, activation of host tissues and induction of inflammatory cytokines secretion. Increased expression of major histocompatibility complex (MHC) antigens and adhesion molecules leads to enhancement of the recognition of host MHC and/or minor histocompatibility antigens by mature donor T cells. Donor T-cell activation in step II is characterized by the predominance of Th1 cells and the secretion of IL-2 and IFN-gamma. These cytokines induce further T-cell expansion, induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also, nitric oxide (NO) is produced by activated macrophages, and it may contribute to the tissue damage seen during step 3. Lipopolysaccharide (LPS), which leaks through the intestinal mucosa that was damaged during step 1, together with IFN-gamma, from step 2, further stimulate macrophages to secrete cytokines and NO. During step 3, the effector phase, activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B. More... |
Gene mapped KEGG pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
hsa05020 | prion diseases | Prion diseases | Prion diseases, also termed transmissible spongiform encepha...... Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative diseases that affect humans and a number of other animal species. The etiology of these diseases is thought to be associated with the conversion of a normal protein, PrPC, into an infectious, pathogenic form, PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and is thought to occur after PrPC has reached the plasma membrane or is re-internalized for degradation. The PrPSc form shows greater protease resistance than PrPC and accumulates in affected individuals, often in the form of extracellular plaques. Pathways that may lead to neuronal death comprise oxidative stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy, corticosteroid response, and endoplasmic reticulum stress. In addition, the conformational transition could lead to the lost of a beneficial activity of the natively folded protein, PrPC. More... | |
hsa04623 | cytosolic dna_sensing_pathway | Cytosolic DNA-sensing pathway | Specific families of pattern recognition receptors are respo...... Specific families of pattern recognition receptors are responsible for detecting foreign DNA from invading microbes or host cells and generating innate immune responses. DAI is the first identified sensor of cytosolic DNA which activates the IRF and NF-{kappa}B transcription factors, leading to production of type I interferon and other cytokines. The second type of cytoplasmic DNA sensor is AIM2. Upon sensing DNA, AIM2 triggers the assembly of the inflammasome, culminating in interleukin maturation. In addition to these receptors, there is a mechanism to sense foreign DNA, with the host RNA polymerase III converting the DNA into RNA for recognition by the RNA sensor RIG-I. These pathways provide various means to alert the cell. More... | |
hsa04621 | nod like_receptor_signaling_pathway | NOD-like receptor signaling pathway | Specific families of pattern recognition receptors are respo...... Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. NOD1 and NOD2, two prototypic NLRs, sense the cytosolic presence of the bacterial peptidoglycan fragments that escaped from endosomal compartments, driving the activation of NF-{kappa}B and MAPK, cytokine production and apoptosis. On the other hand, a different set of NLRs induces caspase-1 activation through the assembly of multiprotein complexes called inflammasomes. These NLRs include NALP1, NALP3 and Ipaf. The inflammasomes are critical for generating mature proinflammatory cytokines in concert with Toll-like receptor signaling pathway. More... | |
hsa04630 | jak stat_signaling_pathway | Jak-STAT signaling pathway | The Janus kinase/signal transducers and activators of transc...... The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors. More... | |
hsa05410 | hypertrophic cardiomyopathy_hcm | Hypertrophic cardiomyopathy (HCM) | Hypertrophic cardiomyopathy (HCM) is a primary myocardial di...... Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myofibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in 11 genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myofilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction. More... | |
hsa05200 | pathways in_cancer | Pathways in cancer | ||
hsa04640 | hematopoietic cell_lineage | Hematopoietic cell lineage | Blood-cell development progresses from a hematopoietic stem ...... Blood-cell development progresses from a hematopoietic stem cell (HSC), which can undergo either self-renewal or differentiation into a multilineage committed progenitor cell: a common lymphoid progenitor (CLP) or a common myeloid progenitor (CMP). A CLP gives rise to the lymphoid lineage of white blood cells or leukocytes-the natural killer (NK) cells and the T and B lymphocytes. A CMP gives rise to the myeloid lineage, which comprises the rest of the leukocytes, the erythrocytes (red blood cells), and the megakaryocytes that produce platelets important in blood clotting. Cells undergoing these differentiation process express a stage- and lineage-specific set of surface markers. Therefore cellular stages are identified by the specific expression patterns of these genes. More... | |
hsa04060 | cytokine cytokine_receptor_interaction | Cytokine-cytokine receptor interaction | Cytokines are soluble extracellular proteins or glycoprotein...... Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. Cytokines are released by various cells in the body, usually in response to an activating stimulus, and they induce responses through binding to specific receptors on the cell surface of target cells. Cytokines can be grouped by structure into different families and their receptors can likewise be grouped. More... | |
hsa04672 | intestinal immune_network_for_iga_production | Intestinal immune network for IgA production | The intestine is the largest lymphoid tissue in the body. On...... The intestine is the largest lymphoid tissue in the body. One striking feature of intestinal immunity is its ability to generate great amounts of noninflammatory immunoglobulin A (IgA) antibodies that serve as the first line of defense against microorganisms. The basic map of IgA production includes induction of mucosal B cells in the Peyer's patches, circulation through the bloodstream and homing to intestinal mucosa of IgA-commited plasma cells, and local antibody production for export across the intestinal membranes. Multiple cytokines, including TGF-{beta}, IL-10, IL-4, IL-5, and IL-6, are required to promote IgA class switching and terminal differentiation process of the B cells. Secreted IgA promotes immune exclusion by entrapping dietary antigens and microorganisms in the mucus and functions for neutralization of toxins and pathogenic microbes. More... | |
hsa04620 | toll like_receptor_signaling_pathway | Toll-like receptor signaling pathway | Specific families of pattern recognition receptors are respo...... Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK. More... |
Gene mapped BioCarta pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
IL17_PATHWAY | il17 pathway | IL 17 Signaling Pathway | Inflammation is a complex response involving many different ...... Inflammation is a complex response involving many different cells and signaling molecules, including the secretion of the cytokine IL-17 by activated T cells. IL-17 secretion is restricted to specific subsets of T cells but the receptor for IL-17 is widely expressed throughout the body, including fibroblasts and epithelial cells. Inflammatory responses involving IL-17 probably contribute to arthritis, asthma, skin immune reactions and autoimmune disorders. Fibroblasts and other cells stimulated by IL-17 are induced themselves to secrete inflammatory and hematopoietic cytokines, including IL-6, IL-8, G-CSF and Stem Cell Factor (SCF). These cytokines in turn provoke a range of activities, including the stimulation of neutrophil proliferation and differentiation. More... | |
IL6_PATHWAY | il6 pathway | IL 6 signaling pathway | Interleukin-6 (IL-6) is a cytokine that provokes a broad ran...... Interleukin-6 (IL-6) is a cytokine that provokes a broad range of cellular and physiological responses. In addition to playing a role in inflammation and hematopoiesis, IL-6 is involved in other processes such as neuronal differentiation and bone loss. To produce these effects IL-6 signals through a receptor composed of two different subunits, an alpha subunit that produces ligand specificity and gp130, a receptor subunit shared in common with other cytokines in the IL-6 family. Binding of IL-6 to its receptor initiates cellular events including activation of JAK kinases and activation of ras-mediated signaling. Activated JAK kinases phosphorylate and activate STAT transcription factors, particularly STAT3, that move into the nucleus to activate transcription of genes containing STAT3 response elements. The ras-mediated pathway, acting through Shc, Grb-2 and Sos-1 upstream and activating Map kinases downstream, activates transcription factors such as ELK-1 and NF-IL-6 (C/EBP-beta) that can act through their own cognate response elements in the genome. These factors and other transcription factors like AP-1 and SRF (serum response factor) that respond to many different signaling pathways come together to regulate a variety of complex promoters and enhancers that respond to IL-6 and other signaling factors. More... | |
IL10_PATHWAY | il10 pathway | IL-10 Anti-inflammatory Signaling Pathway | IL-10 is a cytokine with potent anti-inflammatory properties...... IL-10 is a cytokine with potent anti-inflammatory properties, repressing the expression of inflammatory cytokines such as TNF-alpha, IL-6 and IL-1 by activated macrophages. The IL-10 receptor is in the JAK/STAT class of receptors but activation of the JAK/STAT pathways by IL-10 does not appear on its own to be responsible for the anti-inflammatory properties of this cytokine. The anti-inflammatory actions of IL-10 appear to require induction of the enzyme heme oxygenase-1 (HO-1) through a map kinase pathway involving the p38 kinases. HO-1 is involved in the biosynthesis of heme, and catalyzes a reaction producing carbon monoxide, free iron, and the heme precursor biliverdin. HO-1 is induced by IL-10 and is also induced by oxidative stress. Blocking HO-1 with inhibitors or antisense blocks the anti-inflammatory actions of IL-10. The anti-inflammatory actions of HO-1 appear to be the result of signaling by carbon monoxide it produces since removal of CO blocks the anti-inflammatory action of IL-10 and HO-1. The anti-inflammatory actions of IL-10 may be therapeutically useful either directly or through modulation of HO-1 activity. More... | |
ERYTH_PATHWAY | eryth pathway | Erythrocyte Differentiation Pathway | Stem cells in the bone marrow produce a variety of hematopoi...... Stem cells in the bone marrow produce a variety of hematopoietic cell types from common progenitor cells under the influence of cytokines and growth factors. CFU-GEMM cells are a key intermediate in the differentiation of granulocytes, erythrocytes, monocytes and megakaryocytes. Erythropoietin (EPO) is a cytokine produced in the kidneys that, along with other cytokines, induces red blood cell (erythrocyte) differentiation in the bone marrow from CFU-GEMM cells. As the erythrocyte lineage progresses, cells lose their nuclei, and move out of the bone marrow into circulation. The ability of EPO to selectively induce red blood cell differentiation has allowed extensive therapeutic use of the recombinant form of this cytokine to treat anemias. More... | |
STEM_PATHWAY | stem pathway | Regulation of hematopoiesis by cytokines | The process of hematopoesis is regulated by various cytokine...... The process of hematopoesis is regulated by various cytokines. The combination of cytokines stimulates the proliferation and/or differentiation of the various hematopoietic cell types. Bone marrow stromal cells are the major source of hematopoietic cytokines in the non-infecteous state. In the presence of infection, cytokines produced by activated macrophages and TH cells induce hematopoietic activity. The induction by cytokines results in rapid expansion of the population of white blood cells to fight infection. The specific cytokines that affect a step of cell differentiation are placed adjacent to the arrow representing that step. Lines with ? indicate likely, but still hypothetical pathways. More... | |
HER2_PATHWAY | her2 pathway | Role of ERBB2 in Signal Transduction and Oncology | Her2 or ERBB2 belongs to a class of proteins having high hom...... Her2 or ERBB2 belongs to a class of proteins having high homology with epidermal growth factor receptor (EGFR or ERBB1). It encodes a protein with the molecular weight of 185 KDa. Unlike other members of EGFR family, no ligand for Her2 has been found and it usually associates with members of ERBB1 family to form functional heterodimers. It has been shown that it can form dimers with ERBB (EGFR), ERBB3 and ERBB4 as well as gp130 subunits of IL-6 receptor. In at least some cell types, the association between gp130 and HRBB2 is essential for HRBB2-ERBB3 phosphorylation and subsequent MAP kinase signaling. Although ERBB1 can form homodimers, the signaling for ERBB1 is usually transient and the receptor undergoes internalization after ligand binding and activation. EGFR-HER2 complex increases the signaling capacity of EGFR by increasing the ligand affinity as well as the recycling of the heterodimer. Of all the ERBB heterodimers, ERBB2-ERBB3 heterodimers perhaps elicit the strongest signal. Removing ERBB3 from the cell has a drastic effect on ERBB2 mediated signaling and downstream effectors. The clinical importance of HER2 cannot be overstated. In addition, monoclonal antibody (Herceptin) against this receptor has been shown to be an effective treatment of breast cancer patients who have a high level of HER2 over expression. More... | |
CYTOKINE_PATHWAY | cytokine pathway | Cytokine Network | Several different cell types coordinate their efforts as par...... Several different cell types coordinate their efforts as part of the immune system, including B cells, T cells, macrophages, neutrophils, basophils and eosinophils. Each of these cell types has a distinct role in the immune system, and communicates with other immune cells using secreted factors called cytokines, including interleukins, TNF, and the interferons. Macrophages phagocytose foreign bodies and are antigen-presenting cells, using cytokines to stimulate specific antigen dependent responses by B and T cells and non-specific responses by other cell types. T cells secrete a variety of factors to coordinate and stimulate immune responses to specific antigen, such as the role of helper T cells in B cell activation in response to antigen. The proliferation and activation of eosinophils, neutrophils and basophils respond to cytokines as well. Cytokine communication is often local, within a tissue or between cells in close proximity. Each of the cytokines is secreted by one set of cells and provokes a response in another target set of cells, often including the cell that secretes the cytokine. Some cytokines, like IL-1, interferons and TNF, stimulate a broad inflammatory response in response to infection or injury. Other cytokines have more specific functions such the following examples. IL-2 stimulates the proliferation and activation of B and T cells. IL-4 plays a role in the differentiation of Th2 cells, in allergic responses, and in the switching of antibody types. IL-5 stimulates the production and maturation of eosinophils during inflammation. IL-8 is a chemokine, a chemotactic factor that attracts neutrophils, basophils and T cells to sites of inflammation. IL-12 and IL-18 are involved in helper T cell differentiation. IL-10 apparently acts to repress secretion of proinflammatory cytokines. The complex interplay of these different cytokine functions with immune cells is essential for correct immune function. More... | |
IL5_PATHWAY | il5 pathway | IL 5 Signaling Pathway | IL-5 is an inflammatory signaling molecule that primarily st...... IL-5 is an inflammatory signaling molecule that primarily stimulates eosinophil proliferation, maturation and activation. Eosinophils are leukocytes involved in inflammatory responses that defend against parasites and cause some aspects of asthma, allergic reactions, and perhaps autoimmune disorders. The action of IL-5 begins with an immune response in tissues, such as activation of macrophages and T cells that secrete IL-1, IL-4 and IL-6. The immune response can lead to IL-5 secretion by T cells, eosinophils and mast cells. Secreted IL-5 stimulates production and maturation of eosinophils in bone marrow that migrate to tissues in response to eotaxin and release factors that damage tissues, causing some of the undesirable consequences of inflammation. The receptor for IL-5 is a heterodimer of an alpha subunit that is required for IL-5 selective binding and a beta subunit that is also part of the IL-3 and GM-CSF receptors. Binding of IL-5 to the IL-5 receptor at the cell surface activates JAK/STAT signaling pathways that regulate transcription, proliferation, and differentiation. More... | |
IL1R_PATHWAY | il1r pathway | Signal transduction through IL1R | Interleukin-1 (IL-1) is a pro-inflammatory cytokine that sig...... Interleukin-1 (IL-1) is a pro-inflammatory cytokine that signals primarily through the type 1 IL-1 receptor (IL-1R1). The activities of IL-1 include induction of fever, expression of vascular adhesion molecules, and roles in arthritis and septic shock. The inflammatory activities of IL-1 are partially derived by transcriptionally inducing expression of cytokines such as TNF-alpha and interferons, as well as inducing the expression of other inflammation-related genes. There are two forms of IL-1 encoded by distinct genes, IL-1 alpha and IL-1 beta. IL-1 beta is produced as a 269 amino acid precursor that is cleaved by IL-1beta converting enzyme (ICE) to the active IL-1 beta form that is secreted. IL-1 signaling is opposed by the naturally occurring peptide IL-1 receptor antagonist which is a therapeutic agent for the treatment of arthritis. The type 1 IL-1 receptor protein binds IL-1 beta but requires the IL-1 receptor accessory protein (IL-1RAcP) to transduce a signal. IL-1 binding causes activation of two kinases, IRAK-1 and IRAK-2, associated with the IL-1 receptor complex. IRAK-1 (IL-1 Receptor Associated Kinase) activates and recruits TRAF6 to the IL-1 receptor complex. TRAF6 activates two pathways, one leading to NF-kB activation and another leading to c-jun activation. The TRAF associated protein ECSIT leads to c-Jun activation through the Map kinase/JNK signaling system. TRAF6 also signals through the TAB1/TAK1 kinases to trigger the degradation of I-kB, and activation of NF-kB. The IL-1 signaling cascade represents a highly conserved response to pathogens through evolution, with homologs in insects and even in plants. The signal transduction cascade utilized by IL-1 receptor is similar to that of TNF, resulting in NF-kB activation, and is most similar to that of the Toll-like receptors that also participate in inflammatory signaling responses to pathogen components like endotoxin. More... | |
INFLAM_PATHWAY | inflam pathway | Cytokines and Inflammatory Response | Inflammation is a protective response to infection by the im...... Inflammation is a protective response to infection by the immune system that requires communication between different classes of immune cells to coordinate their actions. Acute inflammation is an important part of the immune response, but chronic inappropriate inflammation can lead to destruction of tissues in autoimmune disorders and perhaps neurodegenerative or cardiovascular disease. Secreted cytokine proteins provide signals between immune cells to coordinate the inflammatory response. Some cytokines such as IL-1, IL-6 and TNF act to broadly provoke the inflammatory response while others act on specific types of immune cells. Macrophages and other phagocytotic cells provide a front-line defense against bacterial infection. Macrophages stimulate the inflammatory responses of neutrophils, fibroblasts, and endothelial cells in response infection by secreting IL-1 and TNF. IL-1 and TNF cause fever through alteration of the body temperature set-point in the hypothalamus. Fibroblasts and endothelial cells respond to IL-1 and TNF by recruiting more immune cells to the site of inflammation. Secreted IL-8 is a chemokine that attracts neutrophils to sites of infection. Macrophages also present antigen to T helper cells that play a central role in coordinating immune responses. T helper cells induce clonal expansion of T cells that respond to antigen, with IL-2 as a key mediator of T cell proliferation and activation. TGF-beta is a negative regulator of proliferation in many cells, have anti-inflammatory actions in some settings. The cytotoxic activity of Natural Killer cells (NK cells) and lymphokine activated killer cells (LAK cells) toward viral infected or tumor cells is stimulated by IL-2 and other cytokines. T helpers secrete IL-3 and IL-5 to stimulate eosinophil proliferation and activation. Eosinophils are involved in the immune response to parasitic infection. T helper cells are required to stimulate B cell responses as well, with the cytokines IL-10, IL-4 and other cytokines regulating the clonal selection and differentiation of antigen-specific B cells to form antibody-secreting plasma B cells and memory cells. In addition to inducing activation and proliferation of specific differentiated immune cells, cytokines act on hematopoeitic stem cells, causing their proliferation and differentiation into the full range of immune cells. More... | |
LAIR_PATHWAY | lair pathway | Cells and Molecules involved in local acute inflammatory response | Inflammation has several distinct components, including the ...... Inflammation has several distinct components, including the localized response at the site of tissue injury or infection. Tissue injury stimulates the release of inflammatory signaling molecules such as bradykinin. Bacterial infection stimulates an immune response in several ways. Bacteria that are phagocytosed can activate macrophages, causing the release of inflammatory cytokines such as IL-1, TNF, and IL-6. Bacteria can also activate the complement cascade through either the antibody-mediated pathway (classical pathway) or the alternative complement pathway. In extravascular tissues, cells that respond to infection or injury include macrophages and mast cells. Macrophages and other immune cells secrete chemokines that recruit leukocytes from the circulation to the site of inflammation. Mast cells release histamine, prostaglandins, and leukotrienes that act as chemokines, increase vascular permeability, and act on the vascular endothelium to increase tissue recruitment of leukocytes. Chemokines can recruit leukocytes or lymphocytes out of the blood stream into tissues and make blood vessels more permeable. Leukocytes are activated by inflammatory signals to express adhesion molecules that cause them to interact with the vascular endothelium, penetrate the endothelial wall and migrate into the extracellular space of tissues. The combined response of immune cells and signaling molecules at the site of inflammation induces swelling, activation of immune cells, and clearance of potential infectious agents. Chronic inflammation can however also lead to tissue damage in conditions such as arthritis, in which anti-inflammatory drugs act on various steps in inflammation to prevent disease. More... |
IL6 related interactors from protein-protein interaction data in HPRD (count: 5)